Title |
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
|
---|---|
Published in |
Journal of Translational Medicine, February 2013
|
DOI | 10.1186/1479-5876-11-31 |
Pubmed ID | |
Authors |
Hussein Fayyad-Kazan, Nizar Bitar, Mehdi Najar, Philippe Lewalle, Mohammad Fayyad-Kazan, Rabih Badran, Eva Hamade, Ahmad Daher, Nader Hussein, Rim ELDirani, Fadwa Berri, Luc Vanhamme, Arsène Burny, Philippe Martiat, Redouane Rouas, Bassam Badran |
Abstract |
MicroRNAs (miRNAs) are small (19-22-nt) single-stranded noncoding RNA molecules whose deregulation of expression can contribute to human disease including the multistep processes of carcinogenesis in human. Circulating miRNAs are emerging biomarkers in many diseases and cancers such as type 2 diabetes, pulmonary disease, colorectal cancer, and gastric cancer among others; however, defining a plasma miRNA signature in acute myeloblastic leukemia (AML) that could serve as a biomarker for diagnosis or in the follow-up has not been done yet. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | <1% |
Australia | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 108 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 19 | 17% |
Student > Master | 19 | 17% |
Researcher | 13 | 12% |
Student > Postgraduate | 6 | 5% |
Professor > Associate Professor | 6 | 5% |
Other | 20 | 18% |
Unknown | 28 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 22% |
Biochemistry, Genetics and Molecular Biology | 24 | 22% |
Agricultural and Biological Sciences | 20 | 18% |
Chemistry | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 5 | 5% |
Unknown | 33 | 30% |